Amalgamated Bank’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-12,561
| Closed | -$226K | – | 1529 |
|
|
2020
Q2 | $226K | Sell |
12,561
-859
| -6% | -$11.9K | 0.01% | 1243 |
|
|
2020
Q1 | $96K | Sell |
13,420
-112
| -0.8% | -$1.4K | ﹤0.01% | 1498 |
|
|
2019
Q4 | $323K | Buy |
13,532
+993
| +8% | +$27.4K | 0.01% | 1365 |
|
|
2019
Q3 | $336K | Buy |
12,539
+531
| +4% | +$14.9K | 0.01% | 1251 |
|
|
2019
Q2 | $326K | Buy |
12,008
+2,204
| +22% | +$69.1K | 0.01% | 1311 |
|
|
2019
Q1 | $340K | Buy |
+9,804
| New | +$283K | 0.01% | 1185 |
|
|
2018
Q3 | – | Sell |
-9,890
| Closed | -$374K | – | 1699 |
|
|
2018
Q2 | $374K | Buy |
9,890
+2,286
| +30% | +$87.4K | 0.01% | 1184 |
|
|
2018
Q1 | $248K | Sell |
7,604
-133
| -2% | -$5.84K | 0.01% | 1331 |
|
|
2017
Q4 | $377K | Buy |
7,737
+712
| +10% | +$36K | 0.01% | 1140 |
|
|
2017
Q3 | $380K | Buy |
7,025
+649
| +10% | +$38.1K | 0.01% | 1073 |
|
|
2017
Q2 | $358K | Buy |
6,376
+328
| +5% | +$13.1K | 0.01% | 1097 |
|
|
2017
Q1 | $237K | Buy |
+6,048
| New | +$193K | 0.01% | 1286 |
|
|
2016
Q1 | – | Sell |
-4,797
| Closed | -$247K | – | 1314 |
|
|
2015
Q4 | $247K | Sell |
4,797
-42
| -0.9% | -$2.04K | 0.03% | 924 |
|
|
2015
Q3 | $206K | Buy |
4,839
+58
| +1% | +$2.8K | 0.02% | 1136 |
|
|
2015
Q2 | $218K | Buy |
+4,781
| New | +$192K | 0.02% | 1199 |
|
Amalgamated Bank's PTLA Position: Q3 2020 in Review
Amalgamated Bank sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 12,561 shares — an estimated $226K sold.
Amalgamated Bank first reported a position in PTLA in Q2 2015 and held it in 15 quarters. The position peaked at $380K in Q3 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Amalgamated Bank reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Amalgamated Bank sold 12,561 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $226K.
- Amalgamated Bank first reported a position in Portola Pharmaceuticals, Inc. in Q2 2015 and held it in 15 quarters.
- Amalgamated Bank's Portola Pharmaceuticals, Inc. position peaked at $380K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Amalgamated Bank's 13F filing for Q3 2020, filed 30 Oct 2020.